Loading...
XHKG
0609
Market cap125mUSD
Jun 13, Last price  
1.12HKD
1D
0.00%
1Q
-0.88%
Jan 2017
-43.15%
IPO
76.38%
Name

Tiande Chemical Holdings Ltd

Chart & Performance

D1W1MN
P/E
13.44
P/S
0.48
EPS
0.08
Div Yield, %
10.71%
Shrs. gr., 5y
0.52%
Rev. gr., 5y
6.29%
Revenues
1.87b
-9.93%
430,817,000504,187,000574,298,000725,199,000598,947,000881,775,000972,163,0001,003,895,0001,195,178,0001,121,127,0001,123,408,0001,265,389,0001,407,329,0001,179,300,0001,381,138,0001,359,393,0002,584,731,0003,520,608,0002,080,285,0001,873,801,000
Net income
67m
-68.31%
41,711,00058,018,00021,554,00024,925,00042,044,000129,226,000132,360,000159,182,000188,086,000154,505,000172,371,000219,603,000101,562,000-61,058,00021,507,00094,821,000379,647,000870,924,000211,071,00066,879,999
CFO
0k
-100.00%
61,124,0004,647,00031,591,00083,629,00047,198,000154,489,00091,288,000218,577,000174,672,000152,634,000199,392,000241,095,000277,374,00016,767,000245,150,000170,532,000274,331,000854,842,000649,233,0000
Dividend
Aug 04, 20250.03 HKD/sh
Earnings
Aug 25, 2025

Profile

Tiande Chemical Holdings Limited, an investment holding company, engages in the research, development, manufacture, sale, and distribution of fine chemical products in the People's Republic of China, India, the United States, Taiwan, the United Kingdom, and internationally. Its principal products include sodium cyanide, cyanoacetic acid and cyanoacetates, malonates, diethyl ethoxymethylenemalonate, EDTA acids and salts, mono chloroacetic acid and derivatives, ethanol, tert-butanol, cyanoacrylate monomers, and related by-products. The company also engages in the research and development, manufacture, and sale of medical instrument products; and manufacture and sale of adhesive products. Its products are used in synthesis of pharmaceutical products, pesticides, adhesive products, sealants, essences, aromatics, etc. The company was founded in 1997 and is headquartered in Weifang, the People's Republic of China. Tiande Chemical Holdings Limited is a subsidiary of Cheerhill Group Limited.
IPO date
Oct 27, 2006
Employees
1,591
Domiciled in
HK
Incorporated in
KY

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
1,873,801
-9.93%
2,080,285
-40.91%
3,520,608
36.21%
Cost of revenue
1,932,956
1,812,589
2,334,017
Unusual Expense (Income)
NOPBT
(59,155)
267,696
1,186,591
NOPBT Margin
12.87%
33.70%
Operating Taxes
20,776
66,627
326,964
Tax Rate
24.89%
27.55%
NOPAT
(79,931)
201,069
859,627
Net income
66,880
-68.31%
211,071
-75.76%
870,924
129.40%
Dividends
(186,646)
(243,290)
Dividend yield
14.53%
12.81%
Proceeds from repurchase of equity
18,055
BB yield
-0.95%
Debt
Debt current
220,134
45,724
Long-term debt
Deferred revenue
Other long-term liabilities
45,002
Net debt
(631,420)
(615,063)
(1,671,508)
Cash flow
Cash from operating activities
649,233
854,842
CAPEX
(318,469)
(262,102)
Cash from investing activities
(543,418)
(469,451)
Cash from financing activities
(232,546)
(337,125)
FCF
(8,414)
197,742
529,328
Balance
Cash
851,554
615,063
492,130
Long term investments
1,225,102
Excess cash
757,864
511,049
1,541,202
Stockholders' equity
2,514,924
2,419,299
2,365,885
Invested Capital
2,022,196
2,046,527
937,387
ROIC
13.48%
115.12%
ROCE
10.28%
46.97%
EV
Common stock shares outstanding
874,192
873,606
867,510
Price
1.14
-22.45%
1.47
-32.88%
2.19
64.66%
Market cap
996,579
-22.40%
1,284,201
-32.41%
1,899,847
67.67%
EV
459,980
783,797
322,680
EBITDA
(59,155)
405,855
1,315,806
EV/EBITDA
1.93
0.25
Interest
176
2,767
Interest/NOPBT
0.07%
0.23%